| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis |
| 04/17/2003 | CA2462582A1 Adjuvants for nucleic acid vaccines |
| 04/17/2003 | CA2462209A1 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 04/17/2003 | CA2462185A1 Methods for modulating activity of the fxr nuclear receptor |
| 04/17/2003 | CA2461064A1 Inhibition of stat-1 |
| 04/17/2003 | CA2458392A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/16/2003 | EP1302539A1 Tumor-specific promoters |
| 04/16/2003 | EP1302536A2 Embryonic stem cells and neural progenitor cells derived therefrom |
| 04/16/2003 | EP1301798A2 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 04/16/2003 | EP1301795A2 Method of identifying and/or isolating stem cells |
| 04/16/2003 | EP1301616A2 Bicistronic influenza viruses comprising two genes in tandem |
| 04/16/2003 | EP1301615A2 Adenovirus vectors comprising introns |
| 04/16/2003 | EP1301614A1 Codon-optimized papilloma virus sequences |
| 04/16/2003 | EP1301613A2 Modified virus having an altered tropism |
| 04/16/2003 | EP1301612A2 Method and composition for targeting an adenoviral vector |
| 04/16/2003 | EP1301611A2 Human rrp sequences and methods of use |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301593A2 ANTISENSE COMPOSITIONS TARGETED TO $g(b) 1? ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 04/16/2003 | EP1301541A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301214A2 Methods of transducing neural cells using lentivirus vectors |
| 04/16/2003 | EP1301213A2 Multi-component biological transport systems |
| 04/16/2003 | EP1301211A2 Multifunctional nanodevice platform |
| 04/16/2003 | EP1301199A2 Methods for therapy of neurodegenerative disease of the brain |
| 04/16/2003 | EP1301198A2 Fusion protein for inhibition of lipoprotein secretion |
| 04/16/2003 | EP1301195A2 Pharmaceutical use of fibulin-1 |
| 04/16/2003 | EP1301182A2 Use of matrix metalloprotease inhibitors for the treatment of cancer |
| 04/16/2003 | EP1220896A4 Novel human lipase proteins, nucleic acids encoding them, and uses of both of these |
| 04/16/2003 | EP1200105A4 Modified factor viii |
| 04/16/2003 | EP1096921B1 Liposomal encapsulated nucleic acid-complexes |
| 04/16/2003 | EP1009442B1 Improvements in or relating to regulation of t cell activation |
| 04/16/2003 | EP0871483B1 Helper virus-free aav production |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0789591B1 Methods for identifying individuals suffering from a cellular abnormality |
| 04/16/2003 | EP0648271B1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/16/2003 | EP0591462B1 Universal donor cells |
| 04/16/2003 | CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them |
| 04/16/2003 | CN1411508A Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 04/16/2003 | CN1410128A Plasmid used directly in intramuscular injection for treating diabetes |
| 04/16/2003 | CN1105725C Modulators for functions of FAS/APO1 receptors |
| 04/15/2003 | US6548739 Method for activating peroxisome proliferator activated receptor-γ |
| 04/15/2003 | US6548631 Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection |
| 04/15/2003 | US6548302 Polymers for delivery of nucleic acids |
| 04/15/2003 | US6548287 Non-pyrogenic bacterial strains and use of the same |
| 04/15/2003 | US6548286 Methods for increasing the efficiency of recombinant AAV product |
| 04/15/2003 | US6548272 Pathogenic gene for bipolar affective disorder |
| 04/15/2003 | US6548258 Methods for diagnosing tuberous sclerosis by detecting mutation in the TSC-1 gene |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | US6547769 Catheter apparatus with weeping tip and method of use |
| 04/11/2003 | WO2002030961A1 Novel peptides |
| 04/11/2003 | CA2425769A1 Novel peptides |
| 04/10/2003 | WO2003029778A2 Novel secreted proteins and their uses |
| 04/10/2003 | WO2003029486A2 Single nucleotide polymorphisms predicting cardiovascular disease |
| 04/10/2003 | WO2003029474A1 Method of regulating expression of gene carried on viral vector |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029459A2 Micro-rna molecules |
| 04/10/2003 | WO2003029448A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 04/10/2003 | WO2003029434A2 Novel molecules of the hkid-1-related protein family and uses thereof |
| 04/10/2003 | WO2003029433A2 Chimeric viral vectors for gene therapy |
| 04/10/2003 | WO2003029429A2 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029414A2 INTRODUCTION OF THE WLDs GENE FOR PREVENTION OF AXONAL DEGENERATION IN NEUROLOGICAL DISEASES |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029412A2 Restricted expression lentivial vectors |
| 04/10/2003 | WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029289A2 Fragements of heat shock proteins and their use |
| 04/10/2003 | WO2003029288A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein |
| 04/10/2003 | WO2003029274A2 Paramyxoviruses as gene transfer vectors to lung cells |
| 04/10/2003 | WO2003028768A1 Remedies |
| 04/10/2003 | WO2003028759A1 Rsv gene expression vaccine |
| 04/10/2003 | WO2003028657A2 Compositions for oral gene therapy and methods of using same |
| 04/10/2003 | WO2003028656A2 Adjuvant compositions |
| 04/10/2003 | WO2003028636A2 Antisense modulation of il-1 receptor-associated kinase-4 expression |
| 04/10/2003 | WO2003028634A2 Method of treatment using ligand-immunogen conjugates |
| 04/10/2003 | WO2003028632A2 Development of a preventive vaccine for filovirus infection in primates |
| 04/10/2003 | WO2003028590A1 Rational drug therapy device and methods |
| 04/10/2003 | WO2003028543A2 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 04/10/2003 | WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | WO2003028536A2 Methods for diagnosing and treating heart disease |
| 04/10/2003 | WO2003028457A1 Method of restoring ciliated cell motility |
| 04/10/2003 | WO2003028441A1 Gene therapy for the prevention of autoimmune disease |
| 04/10/2003 | WO2003015711A9 Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/10/2003 | WO2003006607A9 Inhibition of apoptosis process and improvement of cell performance |
| 04/10/2003 | WO2003005812A3 Modulation of metabolism of steroids and xenobiotics |
| 04/10/2003 | WO2003002598A3 Peptides for use as translocation factors |
| 04/10/2003 | WO2002096467A3 Pharmaceutical use for secreted bacterial effector proteins |
| 04/10/2003 | WO2002081704A3 Regulation of human protein kinase-like protein |
| 04/10/2003 | WO2002080982A9 Nucleic acid mucosal immunization |
| 04/10/2003 | WO2002072826A3 Neurotrophic factors |
| 04/10/2003 | WO2002070692A3 Abca9 transporter and uses thereof |
| 04/10/2003 | WO2002060412A3 Stabilised polymeric aerosols for pulmonary gene delivery |
| 04/10/2003 | WO2002057460A3 Polynucleotides encoding human phosphatases |
| 04/10/2003 | WO2002050122A3 Means for the diagnosis and therapy of ctcl |
| 04/10/2003 | WO2002040674A3 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 04/10/2003 | WO2002033058A3 Novel cysteine proteases and uses thereof |